Editor's favorite: "Crohn Disease: FDG PET/CT Before and After Initial Dose of AntiYTumor NecrosisFactor Therapy to Predict Long-term Response".  Epelboym and colleagues at Brigham and Women's Hospital present a prospective pilot study of 8 patients with Chrohn Disease treated with anti-tumor necrosis factor and sequentially imaging with FDG PET/CT. Brigham and Women's Hospital.  Of 8 patients, 7 showed FDG activity decline at 2 weeks, 5 of whom achieved a clinical response and steroid-free remission at 8, 26, and 52 weeks. The remaining 2 patients with FDG activity decline did not achieve a clinical response or steroid-free remission at these time points, but there were reductions in CRP. This may be yet another application of FDG PET/CT in inflammatory conditions.​

Current Issue



ACR–ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders

Subramaniam, Rathan M.; Frey, Kirk A.; Hunt, Christopher H.; More

Clinical Nuclear Medicine. 42(11):847-852, November 2017.



Application of the Radio-Guided Occult Lesion Localization Technique for Renal Lumpectomy: From the Laboratory to the Patient

Betancourt Hernández, Jesus Andres; Vera Donoso, Cesar; Martinez-Sarmiento, Manuel; More

Clinical Nuclear Medicine. 42(11):e467-e468, November 2017.

1 2 3 4 5